tiprankstipranks
Trending News
More News >

Compass Pathways assumed with an Overweight at Cantor Fitzgerald

Cantor Fitzgerald assumed coverage of Compass Pathways (CMPS) with an Overweight rating and $12 price target This is an important year for the psychedelic space in general with multiple randomized clinical trial data readouts, the analyst tells investors in a research note. The firm thinks there is potentially more upside to shares than options imply.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1